CytoSorbents Europe GmbH

CytoSorbents is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product CytoSorb® is a CE approved extracorporeal cytokine adsorber, designed to broadly reduce cytokine storm and other inflammatory mediators in the blood that could otherwise lead to uncontrolled systemic inflammation, organ failure, and death in many life-threatening illnesses. CytoSorb has been used safely in more than 121,000 treatments worldwide, primarily in the treatment of systemic hyperinflammation in a wide variety of life-threatening conditions. CytoSorb® is distributed in over 60 countries around the world. For more information visit www.cytosorb.com